Table I.
Patient characteristics.
| UPN | Age (years) |
Type of transplant |
Months since transplant |
Immunosuppression | WBC (×109/1) |
Platelets (×109/1) |
Absolute CD4 (×109/1) |
Absolute CD8 (×109/1) |
Mono (% of WBC) |
mDC (×109/1) |
pDC (×109/1) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 01 | 5 | Auto | 3.3 | No | 3.25 | 200 | 0.077 | 0.045 | 6 | 0.040 | 0.0023 |
| 02 | 8 | MSD | 4 | FK506 | 3.73 | 190 | 0.129 | 0.032 | 8 | 0.061 | 0.0039 |
| 03 | 13 | URD | 14.8 | No | 5.11 | 230 | 0.720 | 0.313 | 6 | 0.047 | 0.0024 |
| 04 | 13 | MSD | 21.4 | FK506 | 6.04 | 163 | 0.736 | 1.361 | 5 | 0.042 | 0.0027 |
| 05 | 14 | MSD | 21.6 | MMF | 5.47 | 348 | 0.732 | 0.748 | 4 | 0.017 | 0.0014 |
WBC, white blood cell count; mono, monocytes; pDC, plasmacytoid dendritic cells (Lin−/HLA-DR+/CD11c−/CD123+); mDC, monocytoid dendritic cells (Lin−/HLA-DR+/CD11c+/CD123−); URD, unrelated donor; auto, autologous donor; MSD, matched sibling donor; FK506, tacrolimus; MMF, mycophenolate mofetil.